Immunopeptidomics-based design of mRNA vaccine formulations against Listeria monocytogenes.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
14 10 2022
Historique:
received: 15 07 2022
accepted: 29 09 2022
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 19 10 2022
Statut: epublish

Résumé

Listeria monocytogenes is a foodborne intracellular bacterial pathogen leading to human listeriosis. Despite a high mortality rate and increasing antibiotic resistance no clinically approved vaccine against Listeria is available. Attenuated Listeria strains offer protection and are tested as antitumor vaccine vectors, but would benefit from a better knowledge on immunodominant vector antigens. To identify novel antigens, we screen for Listeria peptides presented on the surface of infected human cell lines by mass spectrometry-based immunopeptidomics. In between more than 15,000 human self-peptides, we detect 68 Listeria immunopeptides from 42 different bacterial proteins, including several known antigens. Peptides presented on different cell lines are often derived from the same bacterial surface proteins, classifying these antigens as potential vaccine candidates. Encoding these highly presented antigens in lipid nanoparticle mRNA vaccine formulations results in specific CD8

Identifiants

pubmed: 36241641
doi: 10.1038/s41467-022-33721-y
pii: 10.1038/s41467-022-33721-y
pmc: PMC9562072
doi:

Substances chimiques

Bacterial Proteins 0
Bacterial Vaccines 0
Immunodominant Epitopes 0
Lipid Nanoparticles 0
Liposomes 0
Membrane Proteins 0
Vaccines, Attenuated 0
Vaccines, Synthetic 0
mRNA Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6075

Informations de copyright

© 2022. The Author(s).

Références

Anal Chem. 2020 Jul 7;92(13):9194-9204
pubmed: 32502341
Curr Microbiol. 2012 Dec;65(6):813-8
pubmed: 23001425
Infect Immun. 2013 Apr;81(4):1334-40
pubmed: 23403554
N Engl J Med. 2020 May 21;382(21):1969-1973
pubmed: 32227757
Infect Immun. 1997 Dec;65(12):5326-9
pubmed: 9393833
Trends Microbiol. 2012 Aug;20(8):360-8
pubmed: 22652164
NPJ Vaccines. 2020 Jan 3;5(1):2
pubmed: 31908851
Nucleic Acids Res. 2021 Jan 8;49(D1):D274-D281
pubmed: 33167031
Bioinformatics. 2005 Sep 1;21(17):3584-5
pubmed: 16030071
Immunogenetics. 2009 Jan;61(1):1-13
pubmed: 19002680
Mol Cell Proteomics. 2012 Apr;11(4):M111.010587
pubmed: 22186715
Emerg Infect Dis. 2021 Sep;27(9):2485-2488
pubmed: 34424172
Science. 2004 Apr 9;304(5668):242-8
pubmed: 15073367
J Biol Chem. 2018 Aug 31;293(35):13626-13635
pubmed: 29976754
J Immunol. 1999 Oct 15;163(8):4510-8
pubmed: 10510394
BMC Immunol. 2012 Apr 26;13:22
pubmed: 22537317
J Cell Biol. 1997 Sep 22;138(6):1255-64
pubmed: 9298981
J Proteome Res. 2019 Feb 1;18(2):709-714
pubmed: 30576148
Mol Cell Proteomics. 2018 Mar;17(3):533-548
pubmed: 29242379
BMC Bioinformatics. 2013;14 Suppl 4:S2
pubmed: 23514126
J Med Microbiol. 2013 Feb;62(Pt 2):185-190
pubmed: 23105022
Nat Rev Immunol. 2013 Feb;13(2):101-17
pubmed: 23334244
Protein Sci. 2003 May;12(5):1007-17
pubmed: 12717023
Genome Med. 2015 Nov 20;7:118
pubmed: 26589293
Sci Transl Med. 2021 Nov 17;13(620):eabj9827
pubmed: 34788080
Front Immunol. 2021 Apr 19;12:632304
pubmed: 33953709
FEMS Microbiol Lett. 2000 Sep 15;190(2):323-8
pubmed: 11034299
Proc Natl Acad Sci U S A. 1975 Dec;72(12):4780-4
pubmed: 1108000
Nucleic Acids Res. 2015 Jan;43(Database issue):D261-9
pubmed: 25428365
Vaccine. 2017 Jan 5;35(2):361-368
pubmed: 27939014
Electrophoresis. 1999 Aug;20(11):2269-79
pubmed: 10493131
N Engl J Med. 2013 Sep 5;369(10):944-53
pubmed: 24004121
Trends Microbiol. 2021 Nov;29(11):1034-1045
pubmed: 34030969
J Immunol. 2018 Dec 15;201(12):3705-3716
pubmed: 30429286
J Immunol. 2016 Sep 15;197(6):2492-9
pubmed: 27511729
Methods Mol Biol. 2019;1988:123-136
pubmed: 31147937
J Immunol. 2005 Jul 15;175(2):1137-44
pubmed: 16002715
Vaccine. 2012 Mar 30;30(16):2633-9
pubmed: 22365841
Appl Environ Microbiol. 2004 Aug;70(8):4458-67
pubmed: 15294773
Cell Rep. 2021 Dec 14;37(11):110112
pubmed: 34863353
J Immunol. 2001 Feb 1;166(3):1877-84
pubmed: 11160235
J Immunol. 2008 Feb 15;180(4):2459-65
pubmed: 18250455
Front Immunol. 2021 Sep 16;12:729837
pubmed: 34603305
Am J Vet Res. 2009 Mar;70(3):383-8
pubmed: 19254151
Front Microbiol. 2018 May 15;9:974
pubmed: 29867877
J Immunol Methods. 2015 Sep;424:111-9
pubmed: 26031451
FEBS Lett. 2001 Aug 3;502(3):113-6
pubmed: 11583110
Infect Immun. 2004 Nov;72(11):6324-9
pubmed: 15501761
Science. 2002 Apr 12;296(5566):356-9
pubmed: 11896235
Nucleic Acids Res. 2020 Jul 2;48(W1):W449-W454
pubmed: 32406916
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
BMC Biotechnol. 2010 Oct 20;10:77
pubmed: 20961459
JAMA. 1987 Mar 13;257(10):1335-40
pubmed: 3029445
Foodborne Pathog Dis. 2017 Jan;14(1):1-7
pubmed: 27982711
PLoS One. 2012;7(8):e42982
pubmed: 22912771
Bioinformatics. 2016 Feb 15;32(4):511-7
pubmed: 26515819
Ther Deliv. 2016;7(5):319-34
pubmed: 27075952
Mol Microbiol. 2002 Nov;46(4):1041-51
pubmed: 12421310
Curr Top Microbiol Immunol. 1996;209:61-77
pubmed: 8742246
Science. 1992 Mar 6;255(5049):1261-3
pubmed: 1546328
Nature. 2009 Jun 18;459(7249):950-6
pubmed: 19448609
J Immunother Cancer. 2021 Apr;9(4):
pubmed: 33858848
J Immunol. 1991 May 15;146(10):3604-16
pubmed: 1709197
Lancet Infect Dis. 2014 Nov;14(11):1073-1082
pubmed: 25241232
Front Cell Infect Microbiol. 2020 Mar 03;10:89
pubmed: 32195198
Nucleic Acids Res. 2021 Jan 8;49(D1):D545-D551
pubmed: 33125081
J Biol Chem. 1982 Sep 25;257(18):10766-9
pubmed: 6955305
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Foodborne Pathog Dis. 2019 Jul;16(7):524-530
pubmed: 31062992
Oncoimmunology. 2014 Aug 03;3(8):e954893
pubmed: 25960936
Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12537-42
pubmed: 16105950
Nucleic Acids Res. 2021 Jul 2;49(W1):W671-W678
pubmed: 34009334
Microbes Infect. 2006 Jul;8(8):2034-43
pubmed: 16798043
PLoS One. 2016 Aug 04;11(8):e0160544
pubmed: 27489951
Bioinformatics. 2020 May 1;36(10):3185-3191
pubmed: 32096826
Nat Commun. 2014 Apr 22;5:3690
pubmed: 24751541
Int J Biol Macromol. 2021 Apr 15;176:567-577
pubmed: 33581203
PLoS One. 2012;7(4):e35503
pubmed: 22536395
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
ACS Nano. 2019 Feb 26;13(2):1655-1669
pubmed: 30742405
Mol Cell Proteomics. 2015 Mar;14(3):658-73
pubmed: 25576301
J Immunol Methods. 2013 Dec 31;400-401:30-6
pubmed: 24144535
Nucleic Acids Res. 2019 Jan 8;47(D1):D339-D343
pubmed: 30357391
J Proteome Res. 2013 Aug 2;12(8):3586-98
pubmed: 23768245
Hum Vaccin Immunother. 2016 Aug 2;12(8):2059-2063
pubmed: 26905522
Nature. 1991 May 23;351(6324):290-6
pubmed: 1709722
J Proteome Res. 2017 Jan 6;16(1):298-306
pubmed: 27802388
J Immunol. 1995 Nov 1;155(9):4355-66
pubmed: 7594595
Front Immunol. 2018 Apr 27;9:912
pubmed: 29780384
EFSA J. 2018 Dec 12;16(12):e05500
pubmed: 32625785
Nucleic Acids Res. 2020 Jan 8;48(D1):D783-D788
pubmed: 31722398
J Immunol. 2017 Nov 1;199(9):3360-3368
pubmed: 28978689
Protein Sci. 2019 Nov;28(11):1947-1951
pubmed: 31441146
N Engl J Med. 2020 Feb 13;382(7):632-643
pubmed: 32053299
J Immunol. 2013 Oct 15;191(8):4152-64
pubmed: 24043891
Nature. 2022 Mar;603(7903):900-906
pubmed: 35296858
Rev Sci Tech. 2006 Aug;25(2):571-80
pubmed: 17094698
Compr Rev Food Sci Food Saf. 2018 Sep;17(5):1277-1292
pubmed: 33350166
Nat Rev Immunol. 2004 Oct;4(10):812-23
pubmed: 15459672
mSystems. 2017 Mar 14;2(2):
pubmed: 28317029
J Proteome Res. 2009 Nov;8(11):5347-55
pubmed: 19754192
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Infect Immun. 2002 Jun;70(6):2926-32
pubmed: 12010981
Front Immunol. 2022 Mar 09;13:855759
pubmed: 35355987
Virulence. 2020 Dec;11(1):391-397
pubmed: 32363991
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Infect Immun. 2019 Jul 23;87(8):
pubmed: 31235641
Front Microbiol. 2019 Oct 24;10:2351
pubmed: 31708880
Cell Host Microbe. 2018 Jun 13;23(6):786-795.e5
pubmed: 29902442
Front Microbiol. 2020 Dec 11;11:569544
pubmed: 33362730
Oncotarget. 2017 Jul 20;8(33):53916-53934
pubmed: 28903312
Helicobacter. 2002 Jun;7(3):175-82
pubmed: 12047323
Eur J Immunol. 2000 Aug;30(8):2216-25
pubmed: 10940913
Genome Med. 2016 Mar 30;8(1):33
pubmed: 27029192
Anal Chem. 2003 Apr 15;75(8):1895-904
pubmed: 12713048
Nat Rev Microbiol. 2018 Jan;16(1):32-46
pubmed: 29176582
Vaccine. 2020 Aug 10;38(36):5803-5813
pubmed: 32684498
Antimicrob Agents Chemother. 1994 Mar;38(3):438-46
pubmed: 8203836
PLoS One. 2017 Nov 27;12(11):e0188288
pubmed: 29176828
Cell Microbiol. 2001 Dec;3(12):853-64
pubmed: 11736996
Interdiscip Perspect Infect Dis. 2010;2010:632513
pubmed: 20204066
Vaccines (Basel). 2018 Jul 25;6(3):
pubmed: 30044426
Nature. 1992 May 21;357(6375):257-60
pubmed: 1589024
Nat Med. 2018 Nov;24(11):1762-1772
pubmed: 30349087
Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1458-63
pubmed: 8643654
Emerg Microbes Infect. 2015 Sep 02;4:e54
pubmed: 26954993
Emerg Infect Dis. 2020 Jul;26(7):1456-1464
pubmed: 32568037
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Microbiol Mol Biol Rev. 2007 Jun;71(2):377-97
pubmed: 17554049
Vaccine. 2003 Jun 1;21 Suppl 2:S102-9
pubmed: 12763691
Anal Chem. 2020 Jan 7;92(1):659-661
pubmed: 31809021
Infect Immun. 2000 Dec;68(12):7069-77
pubmed: 11083832
Nucleic Acids Res. 2009 Jan;37(Database issue):D412-6
pubmed: 18940858
Vaccine. 2015 Apr 27;33(18):2159-66
pubmed: 25738816
Am J Vet Res. 1992 Mar;53(3):368-71
pubmed: 1595962

Auteurs

Rupert L Mayer (RL)

VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
VIB Proteomics Core, VIB, Ghent, Belgium.
Research Institute of Molecular Pathology (IMP), Vienna BioCenter, Vienna, Austria.

Rein Verbeke (R)

Ghent Research Group on Nanomedicines, Ghent University, Ghent, Belgium.
Cancer Research Institute Ghent (CRIG), Ghent, Belgium.

Caroline Asselman (C)

VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.

Ilke Aernout (I)

Ghent Research Group on Nanomedicines, Ghent University, Ghent, Belgium.
Cancer Research Institute Ghent (CRIG), Ghent, Belgium.

Adillah Gul (A)

VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.

Denzel Eggermont (D)

VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.

Katie Boucher (K)

VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
VIB Proteomics Core, VIB, Ghent, Belgium.

Fabien Thery (F)

VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.

Teresa M Maia (TM)

VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
VIB Proteomics Core, VIB, Ghent, Belgium.

Hans Demol (H)

VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
VIB Proteomics Core, VIB, Ghent, Belgium.

Ralf Gabriels (R)

VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.

Lennart Martens (L)

VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.

Christophe Bécavin (C)

Université Côte d'Azur, CNRS, IPMC, Sophia-Antipolis, France.

Stefaan C De Smedt (SC)

Ghent Research Group on Nanomedicines, Ghent University, Ghent, Belgium.
Cancer Research Institute Ghent (CRIG), Ghent, Belgium.

Bart Vandekerckhove (B)

Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Department of Diagnostic Sciences, Ghent University, 9000, Ghent, Belgium.

Ine Lentacker (I)

Ghent Research Group on Nanomedicines, Ghent University, Ghent, Belgium. ine.lentacker@ugent.be.
Cancer Research Institute Ghent (CRIG), Ghent, Belgium. ine.lentacker@ugent.be.

Francis Impens (F)

VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium. francis.impens@vib-ugent.be.
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium. francis.impens@vib-ugent.be.
VIB Proteomics Core, VIB, Ghent, Belgium. francis.impens@vib-ugent.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH